Reid Laurence 4
4 · Decibel Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Reid Laurence
DirectorSee Remarks
Transactions
- Award
Common Stock
2023-03-16+195,000→ 220,849 total - Award
Stock Options (right to buy)
2023-03-16+72,000→ 72,000 totalExercise: $3.73Exp: 2033-03-15→ Common Stock (72,000 underlying)
Footnotes (3)
- [F1]Consists of shares of the Issuer's common stock issuable under 195,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. The RSUs are scheduled to vest with respect to 40% of the shares on January 26, 2024, and with respect to the remainder on January 26, 2025.
- [F2]Includes 195,000 unvested RSUs. Each unvested RSU represents the right to receive one share of the Issuer's common stock upon vesting.
- [F3]The option was granted on March 16, 2023. The shares underlying the option are scheduled to vest with respect to 40% of the shares on January 26, 2024, and with respect to the remainder on January 26, 2025.